naVIGation Invitations Liver surveillANce upTake
NCT06635694 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 652
Last updated 2026-01-14
Summary
This study aims to evaluate the efficacy of Patient Navigators and mailed surveillance invitations on attendance of Hepatocellular Carcinoma (HCC) ultrasound surveillance appointments. The investigators hypothesise that mailed invitations and Patient Navigators will improve attendance at HCC surveillance appointments and increase the proportion of patients diagnosed at an early stage, compared with a control group receiving usual care.
Conditions
- Hepatocellular Carcinoma
- Liver Cirrhosis
- Chronic Hep B
Sponsors & Collaborators
-
RM Partners
collaborator UNKNOWN -
Imperial College London
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-27
- Primary Completion
- 2027-08-19
- Completion
- 2027-08-19
Countries
- United Kingdom
Study Locations
More Related Trials
-
Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC
NCT06435013 ·Status: COMPLETED
-
Targeted Navigation in Hepatocellular Carcinoma (HCC)
NCT06260943 ·Status: RECRUITING ·Phase: NA
-
Bevacizumab in Advanced Hepatocellular Carcinoma
NCT00162669 ·Status: UNKNOWN ·Phase: PHASE2
-
Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma
NCT06146127 ·Status: RECRUITING
-
A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents
NCT05718492 ·Status: RECRUITING ·Phase: NA
-
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
NCT01640522 ·Status: COMPLETED ·Phase: NA
-
Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma
NCT06086002 ·Status: COMPLETED ·Phase: NA
-
SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors
NCT07341321 ·Status: NOT_YET_RECRUITING
-
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
NCT06405321 ·Status: RECRUITING
-
Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment
NCT07147101 ·Status: RECRUITING
-
Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT
NCT06408753 ·Status: COMPLETED
-
Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation
NCT01340105 ·Status: COMPLETED ·Phase: NA
-
Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients
NCT04933435 ·Status: RECRUITING ·Phase: NA
-
Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data
NCT06849180 ·Status: RECRUITING
-
Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma
NCT04627012 ·Status: COMPLETED
-
Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study
NCT04680598 ·Status: UNKNOWN
-
Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC
NCT05546879 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma
NCT00768157 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Antiviral Therapy on Patients With HBV-related HCC
NCT05406089 ·Status: COMPLETED
-
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention for Elevated LFTs
NCT04395118 ·Status: WITHDRAWN ·Phase: NA
-
Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes
NCT07321067 ·Status: NOT_YET_RECRUITING
-
A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma
NCT07063888 ·Status: RECRUITING ·Phase: PHASE2
-
A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors
NCT03695952 ·Status: ACTIVE_NOT_RECRUITING
-
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
NCT00669136 ·Status: TERMINATED ·Phase: PHASE1
-
Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT
NCT06265883 ·Status: COMPLETED